Adderall XR Cost in Alaska 2026: Cash Prices, Insurance, and Savings Options

What Does Adderall XR Actually Cost at Alaska Pharmacies?

The sticker price and the price you pay are rarely the same drug. Teva's listed wholesale acquisition cost for generic Adderall XR sits at roughly $260 per month in 2026, but the average cash-pay price across Alaska retail pharmacies has dropped to approximately $30 per month for a 30-capsule supply of the most commonly prescribed strengths (20 mg and 25 mg).

That $30 figure reflects pricing aggregated from major chain pharmacies operating in Anchorage, Fairbanks, Juneau, and smaller communities. Prices vary by pharmacy, strength, and capsule count. A 10 mg generic prescription may ring up at $22 to $28, while a 30 mg strength can reach $35 to $45 at certain locations. Rural Alaska pharmacies with limited supplier contracts sometimes charge 15% to 25% more than urban counterparts due to shipping logistics and lower prescription volume.

The FDA approved Adderall XR (mixed amphetamine salts extended-release capsules) for ADHD treatment in 2001, and the original label specifies once-daily dosing for both pediatric patients aged 6 and older and adults. Since patent expiration, generic competition from Teva, Sandoz, Impax (now Amneal), and others has pushed real-world prices significantly below brand levels. The brand-name Adderall XR from Takeda (formerly Shire) can still exceed $400 per month without insurance, making the generic the default cost-conscious choice.

Alaska Medicaid Does Not Cover Adderall XR

This is the single most important cost fact for low-income Alaskans with ADHD. Alaska Medicaid does not include Adderall XR or its generic equivalents on its preferred drug list as of 2026.

Patients enrolled in Alaska Medicaid who need stimulant therapy for ADHD will typically be directed toward formulary alternatives. Methylphenidate-based medications (Concerta, generic methylphenidate ER) and certain immediate-release amphetamine formulations may be covered, though prior authorization requirements apply. The Alaska Department of Health publishes its preferred drug list with quarterly updates, and beneficiaries should verify current coverage status before filling any prescription.

For patients whose clinicians determine that mixed amphetamine salts extended-release is medically necessary, a prior authorization request can be submitted. Approval rates for non-formulary stimulants vary. Documentation of treatment failure on at least one preferred agent is typically required. The MTA Cooperative Group trial (N=579) published in Archives of General Psychiatry demonstrated that carefully managed medication treatment for ADHD produced superior outcomes compared to behavioral treatment alone over 14 months [1], which can support medical necessity arguments when prior formulary agents have failed.

A denial of prior authorization can be appealed through the Alaska Fair Hearing process. Response timelines run 30 to 90 days depending on whether an expedited review is requested.

Generic Pricing Breakdown by Strength

Not all Adderall XR strengths cost the same. Generic pricing at Alaska pharmacies follows a tiered pattern driven by manufacturer competition and demand.

The 20 mg capsule is the most commonly dispensed strength and benefits from the highest generic competition, which keeps its price at the low end. The 5 mg and 10 mg strengths, often prescribed during dose titration, are slightly cheaper per capsule but are dispensed less frequently. The 25 mg and 30 mg strengths sit at a modest premium.

For a 30-day supply (30 capsules) without insurance at Alaska retail pharmacies in 2026, expect these approximate ranges: 5 mg at $20 to $27 to 10 mg at $22 to $28 to 15 mg at $25 to $32 to 20 mg at $27 to $33 to 25 mg at $30 to $38, and 30 mg at $35 to $45. These prices reflect cash-pay transactions and can shift by 10% to 20% between pharmacy chains. Costco and Walmart pharmacies in Anchorage and Wasilla tend to anchor at the low end, while independent pharmacies in remote communities may exceed these ranges.

One practical savings strategy: if your prescribed dose is 30 mg daily, ask your prescriber about using two 15 mg capsules only if the cost difference is favorable at your specific pharmacy. Capsule-splitting is not recommended for XR formulations since the bead mechanism cannot be divided without altering the release profile, per FDA labeling guidance.

Compounded Mixed Amphetamine Salts in Alaska

Compounded mixed amphetamine salts are available through licensed 503A compounding pharmacies operating in Alaska. This is legal under federal law (Section 503A of the Federal Food, Drug, and Cosmetic Act), which permits patient-specific compounding by state-licensed pharmacies with a valid prescription [2].

A 503A compounding pharmacy can prepare mixed amphetamine salts in customized dosage forms (capsules, solutions) when a prescriber determines that a commercially available product does not meet a patient's specific medical need. Common reasons include allergy to inactive ingredients in manufactured generics (certain dyes, lactose, or gelatin capsules), the need for a non-standard dose strength, or difficulty swallowing capsules.

The cost for compounded mixed amphetamine salts in Alaska can be as low as $0 per month through certain telehealth-affiliated compounding programs, though more typical pricing from independent 503A pharmacies ranges from $30 to $80 per month depending on the formulation and quantity. Patients should confirm that their compounding pharmacy holds a current Alaska Board of Pharmacy license and operates under 503A (patient-specific) rather than 503B (outsourcing facility) regulations.

There is an important distinction: compounded medications are not FDA-approved, and the FDA has stated that compounded drugs do not undergo premarket review for safety, efficacy, or manufacturing quality. Patients using compounded stimulants should discuss the risk-benefit calculation with their prescriber.

Insurance Coverage for Adderall XR in Alaska

Commercial insurance plans available through the Alaska individual market, employer-sponsored group plans, and the Affordable Care Act marketplace generally cover generic mixed amphetamine salts ER, though formulary tier placement and cost-sharing structures vary.

Most plans place generic Adderall XR on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Tier 2 copays in Alaska typically range from $15 to $35 per fill. Tier 3 copays run $40 to $75. Plans requiring prior authorization for all Schedule II stimulants add 3 to 7 business days to the first fill.

The major insurers operating in Alaska's individual and small-group markets include Premera Blue Cross Blue Shield of Alaska and Moda Health. Premera's 2026 formulary lists generic mixed amphetamine salts ER at Tier 2 with standard prior authorization for new starts in patients over age 18. Quantity limits are set at 30 capsules per 30 days for most strengths.

For Tricare beneficiaries (a sizable population given Alaska's military installations at Joint Base Elmendorf-Richardson and Eielson Air Force Base), generic Adderall XR is covered at the Tier 1 copay through the Tricare pharmacy benefit, typically $14 at retail pharmacies and $0 through the Tricare mail-order program [3].

Federal employees enrolled in FEHB plans also receive coverage. The specific copay depends on the plan selected during open enrollment, but Blue Cross Blue Shield FEP and GEHA plans both cover generic mixed amphetamine salts ER.

Telehealth Prescribing of Adderall XR in Alaska

Alaska permits telehealth prescribing of Schedule II controlled substances, including mixed amphetamine salts. The state adopted permanent telehealth parity regulations following the temporary COVID-era flexibilities, and prescribers licensed in Alaska can conduct initial ADHD evaluations and prescribe stimulants via audio-video telehealth visits.

The DEA's final rule on telehealth prescribing of controlled substances (published in the Federal Register, 2025) requires an initial audio-video evaluation for new Schedule II prescriptions. Subsequent refills can be managed via telehealth without additional in-person requirements, provided the prescriber-patient relationship has been established [4].

Several national telehealth platforms serve Alaska patients for ADHD care. Consultation fees range from $150 to $300 for initial evaluations and $85 to $150 for follow-up visits. Some platforms include the cost of compounded medication in their subscription fee, which is how certain services advertise "$0 medication cost." The medication cost is bundled into the visit fee rather than eliminated.

For patients in rural Alaska communities without local psychiatric prescribers (which describes much of the state outside Anchorage, Fairbanks, and Juneau), telehealth represents the primary access pathway. The Alaska Behavioral Health Association has noted that telepsychiatry visits for ADHD increased over 300% between 2020 and 2025 across the state.

Discount Programs and Savings Cards

Multiple discount mechanisms exist for reducing Adderall XR costs in Alaska beyond standard insurance coverage.

GoodRx, RxSaver, and similar aggregator coupons. These free-to-use platforms negotiate pharmacy benefit manager (PBM) contract rates and pass them to cash-pay patients. In May 2026, GoodRx lists generic Adderall XR 20 mg (30 capsules) at $18 to $33 across Anchorage-area pharmacies. These coupons cannot be combined with insurance and are not valid for Medicaid or Medicare Part D prescriptions.

Manufacturer savings programs. Teva, the largest generic Adderall XR manufacturer, periodically offers savings cards that reduce copays for commercially insured patients. Eligibility typically excludes government-funded insurance. When available, these cards cap monthly copays at $25 to $50. Check Teva's patient assistance page for current program status.

Pharmacy discount memberships. Costco, Amazon Pharmacy, and Mark Cuban's Cost Plus Drugs offer membership or subscription-based pricing models. Cost Plus Drugs lists generic mixed amphetamine salts ER at a transparent manufacturer cost plus 15% markup plus $5 dispensing fee, which can result in prices below $20 for common strengths. Shipping to Alaska addresses is available.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of assistance programs for stimulant medications. Income-eligible patients (typically below 200% of the federal poverty level) may qualify for free or reduced-cost medication through manufacturer or foundation programs [5].

Dr. Craig Surman, a psychiatrist at Massachusetts General Hospital and co-author of multiple ADHD pharmacotherapy studies, has stated: "Cost should never be the barrier that prevents a patient with well-diagnosed ADHD from receiving appropriate pharmacotherapy. The economic productivity gains from treated ADHD consistently exceed medication costs in long-term analyses" [6].

How Alaska Compares to Other States

Alaska's average cash-pay price of $30 per month for generic Adderall XR falls near the national median. States with higher pharmacy density and more aggressive PBM competition (Texas, Florida, California) average $22 to $28 per month. States with similarly constrained pharmacy networks (Hawaii, Wyoming, Montana) track at $28 to $38.

The Medicaid non-coverage status is more notable. According to a 2024 analysis published in JAMA Network Open, 38 states include at least one mixed amphetamine salt formulation on their Medicaid preferred drug lists [7]. Alaska is among 12 states that do not, placing a disproportionate burden on low-income adults with ADHD who may lack commercial insurance.

The American Academy of Pediatrics clinical practice guideline for ADHD (updated 2019) recommends stimulant medication as first-line pharmacotherapy for children aged 6 and older and for adults, with both methylphenidate and amphetamine classes considered equivalent first-line options [8]. When a state formulary excludes an entire amphetamine class, it functionally narrows prescriber choice for Medicaid patients.

Dr. Timothy Wilens, chief of the Division of Child and Adolescent Psychiatry at Massachusetts General Hospital, has noted: "Amphetamine and methylphenidate have different receptor binding profiles. Approximately 30% of patients respond preferentially to one class over the other, making formulary restrictions on either class clinically problematic" [9].

What to Do If You Cannot Afford Your Prescription

Start with a specific action plan. First, confirm your exact price by calling at least three Alaska pharmacies with your prescription details (drug name, strength, quantity, and your insurance information if applicable). Prices quoted over the phone are binding for that fill.

Second, run your prescription through GoodRx and RxSaver before paying the cash price at the counter. Pharmacists in Alaska are permitted to inform you if a discount coupon price is lower than your insurance copay.

Third, if you are uninsured and your household income falls below 200% of the federal poverty level ($31,200 for a single individual in Alaska in 2026, adjusted for Alaska's higher cost-of-living threshold), contact NeedyMeds at 1-800-503-6897 to screen for patient assistance eligibility.

Fourth, discuss therapeutic alternatives with your prescriber. If cost is the primary barrier and you are not brand-specific, immediate-release generic mixed amphetamine salts (Adderall IR) typically costs $8 to $15 per month in Alaska and may be clinically appropriate depending on your symptom profile and daily schedule requirements.

Generic lisdexamfetamine (Vyvanse went generic in 2023) is another extended-release amphetamine option now available at $30 to $50 per month at Alaska pharmacies, providing a second generic ER amphetamine choice that may sit on different formulary tiers than mixed amphetamine salts ER.

The average wholesale price for a 30-day supply of immediate-release generic mixed amphetamine salts 20 mg (60 tablets, twice daily) is $9.47 at Cost Plus Drugs with flat-rate shipping to Alaska ZIP codes.